Wuxi Hyatech Co Ltd
SSE:688510
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (48.2), the stock would be worth ¥23.01 (33% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 71.8 | ¥34.28 |
0%
|
| 3-Year Average | 48.2 | ¥23.01 |
-33%
|
| 5-Year Average | 53.9 | ¥25.74 |
-25%
|
| Industry Average | 77 | ¥36.79 |
+7%
|
| Country Average | 28.8 | ¥13.77 |
-60%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
¥8.4B
|
/ |
Oct 2025
¥122.2m
|
= |
|
|
¥8.4B
|
/ |
Dec 2025
¥259.9m
|
= |
|
|
¥8.4B
|
/ |
Dec 2026
¥330.8m
|
= |
|
|
¥8.4B
|
/ |
Dec 2027
¥414.8m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Wuxi Hyatech Co Ltd
SSE:688510
|
8.9B CNY | 71.8 | 79.3 | |
| US |
|
RTX Corp
LSE:0R2N
|
233.6B USD | 18.3 | 32.2 | |
| US |
|
Raytheon Technologies Corp
NYSE:RTX
|
234.7B USD | 18.4 | 32.3 | |
| US |
|
Boeing Co
NYSE:BA
|
182.4B USD | -57.4 | 96.5 | |
| NL |
|
Airbus SE
PAR:AIR
|
130.6B EUR | 14 | 25 | |
| FR |
|
Safran SA
PAR:SAF
|
112.8B EUR | 18.7 | 15.7 | |
| UK |
|
Rolls-Royce Holdings PLC
LSE:RR
|
95.4B GBP | 17.8 | 16.3 | |
| US |
|
Lockheed Martin Corp
NYSE:LMT
|
117.6B USD | 14.1 | 23.4 | |
| US |
|
Howmet Aerospace Inc
NYSE:HWM
|
97.4B USD | 41.1 | 64.7 | |
| US |
|
General Dynamics Corp
NYSE:GD
|
84.7B USD | 14.3 | 20.1 | |
| US |
|
Northrop Grumman Corp
NYSE:NOC
|
81.7B USD | 14.6 | 17.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.3 |
| Median | 28.8 |
| 70th Percentile | 53.1 |
| Max | 49 021 |
Other Multiples
Wuxi Hyatech Co Ltd
Glance View
Wuxi Hyatech Co Ltd is a China-based company mainly engaged in the research and development, manufacture and sales of key components for aero-engines and medical orthopedic implant forgings. The Company's products include high-performance components such as aviation turbofan engine compressor blades, rotating parts and structural parts, as well as medical orthopedic implant forgings. The Company distributes its products in domestic market and to overseas markets.
